Skip to content

Alpha-GPC vs citicoline: what the evidence shows

Evidence last reviewed Editorial review: NootropicsWork Editorial TeamEducational, not medical advice

The two compounds

Alpha-GPC

Cholinergic (choline-containing phospholipid metabolite)

Citicoline

Choline-containing nucleotide (precursor of the membrane phospholipid phosphatidylcholine)

Grades side by side

OutcomeAlpha-GPCCiticoline
Attention
Strength and power outputNot graded
Psychomotor speedNot graded
Episodic memoryNot graded
MotivationNot graded

Bottom line

Alpha-GPC is a choline supplement [1][2]; citicoline is the supplement and drug form of a compound the body makes [3][4]. Small, supplier-funded alpha-GPC trials in young men gave mixed results for power output and attention [5][6][7]. In a supplier-funded 12-week trial in older adults with memory complaints, citicoline improved some secondary memory scores but not the primary outcome [8].

What the alpha-GPC page found

Alpha-GPC is a choline compound sold as a dietary supplement and, in some countries, as a medicine [1][2]. Small trials in healthy young men, all funded by ingredient suppliers Chemi Nutra or NNB Nutrition, give mixed results for power output and attention [5][6][7]. A Korean cohort linked prescribed alpha-GPC with higher stroke risk, an association not yet confirmed [9][1].

Read the full alpha-GPC evidence page for every graded outcome, the doses used in studies, safety and interactions.

What the citicoline page found

Citicoline (CDP-choline) is the supplement and drug form of a compound the body makes [3][4]. Placebo-controlled trials with Kyowa Hakko-affiliated authors linked it to better memory scores in older adults with memory complaints and better attention in adolescent males [8][10]. EFSA judged the memory evidence insufficient [11]; UK and EU rules say citicoline foods are not for children [12][13].

Read the full citicoline evidence page for every graded outcome, the doses used in studies, safety and interactions.

How to read this comparison

The grades side by side come from each compound's own evidence page and change when either page is re-graded. A grade covers the people and doses in its studies, not every use. This page does not rank one compound above the other; check both safety sections before combining them.

References

  1. Che X, Zhao Y, Xu Z, et al. Unlocking the Potential of l-α-Glycerylphosphorylcholine: From Metabolic Pathways to Therapeutic Applications. Nutr Rev. 2025.PMID 40036805DOI 10.1093/nutrit/nuaf008Tier 1, narrative review
  2. Sagaro GG, Traini E, Amenta F. Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2023.PMID 36683513DOI 10.3233/JAD-221189Tier 1, meta-analysis
  3. Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev. 2005.PMID 15846601DOI 10.1002/14651858.CD000269.pub3Tier 1, meta-analysis
  4. Świątkiewicz M, Grieb P. Citicoline for Supporting Memory in Aging Humans. Aging Dis. 2023.PMID 37196134DOI 10.14336/AD.2022.0913Tier 1, narrative review
  5. Kerksick CM. Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men. Nutrients. 2024.PMID 39683633DOI 10.3390/nu16234240Tier 1, RCT
  6. Marcus L, Soileau J, Judge LW, et al. Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance. J Int Soc Sports Nutr. 2017.PMID 29042830DOI 10.1186/s12970-017-0196-5Tier 1, RCT
  7. Bellar D, LeBlanc NR, Campbell B. The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength. J Int Soc Sports Nutr. 2015.PMID 26582972DOI 10.1186/s12970-015-0103-xTier 1, RCT
  8. Nakazaki E, Mah E, Sanoshy K, et al. Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Nutr. 2021.PMID 33978188DOI 10.1093/jn/nxab119Tier 1, RCT
  9. Lee G, Choi S, Chang J, et al. Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years. JAMA Netw Open. 2021.PMID 34817582DOI 10.1001/jamanetworkopen.2021.36008Tier 1
  10. McGlade E, Agoston AM, DiMuzio J, et al. The Effect of Citicoline Supplementation on Motor Speed and Attention in Adolescent Males. J Atten Disord. 2019.PMID 26179181DOI 10.1177/1087054715593633Tier 1, RCT
  11. EFSA Panel on Nutrition, Novel Foods and Food allergens (NDA), Turck D, Bohn T, et al. 'Citicoline' and support of the memory function: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA J. 2024.PMID 38966137DOI 10.2903/j.efsa.2024.8861Tier 1
  12. Food Standards Agency. Novel food authorisations: Citicoline (NOVEL-34). Updated April 1, 2025.SourceTier 1
  13. European Commission (text via legislation.gov.uk). Commission Implementing Decision 2014/423/EU authorising the placing on the market of citicoline as a novel food ingredient. Updated July 1, 2014.SourceTier 1
Reviewed by NootropicsWork Editorial Team, editorial team. Checklist logged . Next review due . Report an error